FDA-approved
Sexual & reproductive
Human chorionic gonadotropin
Also called hCG
hCG is an FDA-approved hormone that mimics luteinizing hormone. Learn its approved uses, how it works, its risks, and why it is not approved for weight loss.
- Reviewed by
- William Maish, MD MBA MPH, Clinical Product Lead
- Published
- October 5, 2026
- Last updated
- October 5, 2026
Key takeaway
Human chorionic gonadotropin (hCG; FDA-approved injectable brands include Pregnyl and Novarel) is a placental hormone that acts like luteinizing hormone, triggering ovulation in women and testosterone production in men. It is used in fertility treatment, in male hypogonadotropic hypogonadism, and for undescended testicles in boys, and it is not approved for weight loss. In a Cochrane review of seven trials with 1,136 women, recombinant and urinary hCG gave similar ongoing pregnancy or live-birth rates (odds ratio 1.15, 95% confidence interval 0.89 to 1.49).
At a glance
| What it is | A gonadotropin hormone that mimics luteinizing hormone at its receptor |
| Approved for | Ovulation induction in infertility, male hypogonadotropic hypogonadism, and prepubertal undescended testicles |
| Key fact | In assisted reproduction, urinary and recombinant hCG trigger final egg maturation with similar pregnancy outcomes |
| Route | Intramuscular (some products subcutaneous) injection |
| Evidence strength | FDA approved |
What is human chorionic gonadotropin?
Human chorionic gonadotropin, abbreviated hCG, is a glycoprotein hormone normally produced by the placenta in pregnancy. The FDA-approved injectable products, such as Pregnyl and Novarel, are purified from the urine of pregnant women; a separate recombinant version, choriogonadotropin alfa (Ovidrel), is made in the laboratory. hCG shares its structure and action closely with luteinizing hormone, one of the pituitary hormones that controls the ovaries and testes.
How does human chorionic gonadotropin work?
hCG binds the same receptor as luteinizing hormone (the LH/CG receptor) and mimics the natural mid-cycle luteinizing hormone surge. In women undergoing fertility treatment, a dose of hCG triggers the final maturation and release of the egg after the follicles have been grown with other hormones. In men, hCG stimulates the Leydig cells of the testes to produce testosterone and supports sperm production, which is why it is used in hypogonadotropic hypogonadism. In boys with non-anatomical undescended testicles, the testosterone it stimulates can promote testicular descent.
In a Cochrane review, urinary-derived and recombinant hCG gave similar ongoing pregnancy or live-birth rates1 for triggering final egg maturation (odds ratio 1.15, 95% CI 0.89 to 1.49; seven trials, 1,136 women). The FDA has specifically stated that hCG has not been shown2 to be effective for weight loss and is not approved for that use, despite its promotion in some commercial diet programs.
Is it FDA-approved?
Yes, for its hormonal indications. The injectable hCG products have been FDA-approved3 for decades for ovulation induction, male hypogonadism, and cryptorchidism. The agency has separately warned that over-the-counter "homeopathic" hCG weight-loss products are not approved and that prescription hCG is not approved for weight loss.
What is human chorionic gonadotropin prescribed for?
In women, hCG is prescribed to induce ovulation and pregnancy in carefully selected cases of infertility, after the follicles have been developed with follicle-stimulating hormone or menotropins. In men, it is used for hypogonadotropic hypogonadism, and in prepubertal boys for undescended testicles not caused by an anatomical blockage.
Evidence in men comes from small or short studies, summarized below:
| Study | Participants | Finding |
| 2021 systematic review4 pooling 5 hCG trials | 196 men | Mean total testosterone rose from 284.5 to 565.6 ng/dL4 |
| 2018 randomized trial5 of clomiphene, hCG, or both | 282 men with hypogonadism who wanted to preserve fertility | Testosterone rose in all 3 arms5 |
What are the side effects?
According to the prescribing information3, common side effects include:
- Injection-site pain
- Headache
- Fluid retention or edema
- Breast tenderness or gynecomastia (in males)
- Irritability, restlessness, and depression
More serious considerations include:
- Ovarian hyperstimulation syndrome and multiple pregnancy in fertility use
- Signs of early puberty in boys treated for cryptorchidism
- Rare arterial thromboembolism
More for sexual & reproductive
Sources: FDA prescribing information for Pregnyl and Novarel and FDA statements on hCG weight-loss products; a Cochrane review of recombinant versus urinary hCG for triggering egg maturation (Youssef et al., 2016, DOI: 10.1002/14651858.CD003719.pub41), indexed on PubMed. This document is educational and does not constitute medical advice.

